hrcak mascot   Srce   HID

Stručni rad

Antimicrobial Treatment of Oropharyngeal Mucositis During Radio(Chemo)Therapy Treatment of Patients with Head and Neck Cancer

Gordana Berić Jozić   ORCID icon orcid.org/0000-0002-4845-8390 ; Oncology Clinic, University Hospital Mostar, Bosnia and Herzegovina
Ivana Tica Sedlar ; Oncology Clinic, University Hospital Mostar, Bosnia and Herzegovina
Krešimir Tomić ; Oncology Clinic, University Hospital Mostar, Bosnia and Herzegovina

Puni tekst: hrvatski, pdf (379 KB) str. 74-80 preuzimanja: 35* citiraj
APA 6th Edition
Berić Jozić, G., Tica Sedlar, I. i Tomić, K. (2018). Antimikrobno liječenje orofaringealnog mukozitisa tijekom radio-(kemo)terapijskog liječenja bolesnika s karcinomom glave i vrata. Infektološki glasnik, 38 (3), 74-80. Preuzeto s https://hrcak.srce.hr/226999
MLA 8th Edition
Berić Jozić, Gordana, et al. "Antimikrobno liječenje orofaringealnog mukozitisa tijekom radio-(kemo)terapijskog liječenja bolesnika s karcinomom glave i vrata." Infektološki glasnik, vol. 38, br. 3, 2018, str. 74-80. https://hrcak.srce.hr/226999. Citirano 26.01.2020.
Chicago 17th Edition
Berić Jozić, Gordana, Ivana Tica Sedlar i Krešimir Tomić. "Antimikrobno liječenje orofaringealnog mukozitisa tijekom radio-(kemo)terapijskog liječenja bolesnika s karcinomom glave i vrata." Infektološki glasnik 38, br. 3 (2018): 74-80. https://hrcak.srce.hr/226999
Harvard
Berić Jozić, G., Tica Sedlar, I., i Tomić, K. (2018). 'Antimikrobno liječenje orofaringealnog mukozitisa tijekom radio-(kemo)terapijskog liječenja bolesnika s karcinomom glave i vrata', Infektološki glasnik, 38(3), str. 74-80. Preuzeto s: https://hrcak.srce.hr/226999 (Datum pristupa: 26.01.2020.)
Vancouver
Berić Jozić G, Tica Sedlar I, Tomić K. Antimikrobno liječenje orofaringealnog mukozitisa tijekom radio-(kemo)terapijskog liječenja bolesnika s karcinomom glave i vrata. Infektološki glasnik [Internet]. 2018 [pristupljeno 26.01.2020.];38(3):74-80. Dostupno na: https://hrcak.srce.hr/226999
IEEE
G. Berić Jozić, I. Tica Sedlar i K. Tomić, "Antimikrobno liječenje orofaringealnog mukozitisa tijekom radio-(kemo)terapijskog liječenja bolesnika s karcinomom glave i vrata", Infektološki glasnik, vol.38, br. 3, str. 74-80, 2018. [Online]. Dostupno na: https://hrcak.srce.hr/226999. [Citirano: 26.01.2020.]

Sažetak
Oropharyngeal mucositis is a common side effect ocurring after a radio(chemo)therapy treatment of patients with head and neck cancer. It is manifested by erythema, ulceration, severe pain, and up to 85% of patients requiring liquid diet or disabled food/fluid intake. Mucositis is a limiting factor during treatment and symptomatic - supportive measures are necessary for maintaining life quality. Exacerbation can be caused by local infection or trauma. The role of antimicrobial therapy in prevention and treatment is debated and the results of clinical trials are mostly negative or mixed. This paper presents the frequency of oropharyngeal mucositis and the use of antimicrobial therapy in its prevention and treatment in 99 patients treated at Clinic of Oncology, University Clinical Hospital (UCH) Mostar. The incidence of mucositis has
been shown to be consistent with the data disclosed, and the use of antimicrobial drugs is mostly limited to the local application of antimycotics in therapeutic purposes.

Ključne riječi
head and neck cancer; radiotherapy; oropharyngeal mucositis; antimicrobial treatment

Hrčak ID: 226999

URI
https://hrcak.srce.hr/226999

[hrvatski]

Posjeta: 97 *